GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Wednesday broker round-up - UPDATE

Wed, 01st Feb 2012 07:03

Shire Pharmaceuticals: Credit Suisse maintains outperform rating and 2,350p target.Reckitt Benckiser: Credit Suisse maintains outperform rating and 3,800p target.easyJet: Credit Suisse maintains outperform rating and 503p target.Meggitt: Credit Suisse reiterates underperform rating and 330p target.National Grid: Credit Suisse keeps outperform stance and 700p target.ARM Holdings: UBS raises target from 620p to 630p, neutral rating kept; Nomura raises target from 580p to 600p, neutral rating kept.AstraZeneca: Nomura reiterates reduce stance and 2,400p target.BSkyB: Nomura keeps buy rating and 1,000p target; Credit Suisse keeps neutral rating and 610p target.Royal Dutch Shell B: Nomura keeps buy recommendation and 2,800p target.Smith & Nephew: Nomura reiterates neutral rating and 596p target; Credit Suisse keeps neutral rating and 600p target.Morrison: AlphaValue upgrades from reduce to add, target raised from 327.7p to 327.8p.Dixons Retail: AlphaValue upgrades from add to buy, target left at 19.1p.Rockhopper Exploration: Merchant Securities gives buy rating and 428p target.Real Good Food: Merchant Securities confirms hold rating.NWF Group: Charles Stanley downgrades from hold to reduce, target cut from 143p to 100p.

Related Shares

More News
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

5 Jun 2024 09:27

AstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchase

(Alliance News) - AstraZeneca PLC on Wednesday said it successfully completed the acquisition of Boston, Massachusetts-based Fusion Pharmaceuticals In...

3 Jun 2024 08:59

AstraZeneca cancer treatment Tagrisso recommended for approval in EU

(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the Europ...

3 Jun 2024 07:28

AstraZeneca's lung cancer treatment recommended for approval in EU

(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommend...

2 Jun 2024 20:03

Astra's Enhertu breast cancer trial shows 'unprecedented' results

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worse...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.